Evidence map›Paper›PMID 29774012›Full record

ArticleFrontiers in microbiology2018

A Novel Enzyme Portfolio for Red Algal Polysaccharide Degradation in the Marine Bacterium

Mikkel Schultz-Johansen, Pernille K Bech, Rosanna C Hennessy, Mikkel A Glaring, Tristan Barbeyron, Mirjam Czjzek, Peter Stougaard

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Thirteen metagenome-assembled genomes ofMicrobiology resource announcements · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Expanding the application range of theMarine life science & technology · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. A Novel Carrageenan Metabolic Pathway in Flavobacterium algicola.Applied and environmental microbiology · 2022
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Mikkel Schultz-JohansenSection for Microbial Ecology and Biotechnology, Department of Plant and Environmental Sciences, University of Copenhagen, Frederiksberg, Denmark.
Pernille K BechSection for Microbial Ecology and Biotechnology, Department of Plant and Environmental Sciences, University of Copenhagen, Frederiksberg, Denmark.
Rosanna C HennessySection for Microbial Ecology and Biotechnology, Department of Plant and Environmental Sciences, University of Copenhagen, Frederiksberg, Denmark.
Mikkel A GlaringSection for Microbial Ecology and Biotechnology, Department of Plant and Environmental Sciences, University of Copenhagen, Frederiksberg, Denmark.
Tristan BarbeyronSorbonne Université, CNRS, Integrative Biology of Marine Models (LBI2M), Station Biologique de Roscoff (SBR), Roscoff, France.
Mirjam CzjzekSorbonne Université, CNRS, Integrative Biology of Marine Models (LBI2M), Station Biologique de Roscoff (SBR), Roscoff, France.
Peter StougaardSection for Microbial Ecology and Biotechnology, Department of Plant and Environmental Sciences, University of Copenhagen, Frederiksberg, Denmark.
University of Copenhagen · DKStation Biologique de Roscoff · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Marine microbes are a rich source of enzymes for the degradation of diverse polysaccharides.

Indexed as

agarasealgal polysaccharidescarbohydrate-active enzymescarrageenasefurcellaranGH16marine bacteria

Identifiers

PMID29774012
PMCPMC5943477
OpenAlexW2802897430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.